BNTX
BNTX Daily TimeframeSNIPER STRATEGY
This magical strategy works like a clock on almost any charts
Although I have to say it can’t predict pullbacks, so I do not suggest this strategy for leverage trading.
It will not give you the whole wave like any other strategy out there but it will give you huge part of the wave.
The best timeframe for this strategy is Daily, Weekly and Monthly however it can work any timeframe above three minutes.
Start believing in this strategy because it will reward believers with huge profit.
There is a lot more about this strategy.
It can predict and also it can give you almost exact buy or sell time on the spot.
I am developing it even more so stay tuned and start to follow me for more signals and forecasts.
PFE - FDA approval rumour next week FDA approval rumour after hours on friday, which lifted the stock up 4% and BNTX up 6%. There was bullish call activity all last week in Sept and Dec 50 / 55 Call expirations. PFE broke out of all time highs with volume and then backtested that line. Trendline is showing support from July. Look for continuation next week.
These vaccine stocks don't care about market weaknessBoth Moderna and BioNTech are breaking out today on the daily time frame.
The relative strength in these vaccine stocks is something to pay attention to.
Not sure if it means anything for Covid, but with the resurgence of cases making headlines on TV again, we might see continued strength in these names. Breakouts have not been working recently, but the r/r looks good for either of these with a stop below today's low.
Big Crash Incoming On BNTXThere will most likely be a 25% to 35% drop in BNTX over a very short period of time.
If we gap down Tuesday then expect it to drop the whole day.
Reasons: Price and volume divergence, over-extesnion of price and emotions, demand imbalances are way lower, topping formations intra-day.
BioNTech $BNTX making a breakout from flag patternNASDAQ:BNTX is in a strong uptrend, and last week tested its 50 day MA and its bouncing really good. Today is in focus as the price broke out a continuation pattern with good volume. Also, the MACD is close to make a buy signal with a bullish crossover.
BioNTech has a IBD relative strength rating of 97 and is Rank #2 in its industry, just behind NASDAQ:REGN which doesn't have good technicals.
With this buy signal I have a target sell on $266.50 with a 2:1 risk/reward ratio.
In search for the next BNTX, MRNA and NVAX !!Since Covid-19 is here to stay with us with its variants and the vaccines don`t offer lifetime protection, this means that there is room for other companies to develop a better vaccine to address the problem.
And the gains in vaccines stock are quite similar to cryptocurrencies year over year.
From all time low to all time high, BNTX made 19X, MRNA 24X and NVAX 66X.
My question for you is the following: which is the next vaccine developer to make at least 10X our money?? I`m looking forward to discover with you the next big vaccine developer!
And i have a presumption or two which i already shared in my group. And those were the fundamentals i was searching for: data submitted to FDA for Emergency Use Authorization, Phase 3, low Market cap - under 1Bil, on the lower end of 52 Week Range, other drugs in the pipeline, high intraday volume.
$BNTX Ascending Triangle breakout in next 3 days?BNTX has formed an Ascending Triangle indicating breakout in next three days for run to earnings. I've taken some good profits on this since the last earnings, got in at 102, so may be a bit biased.
On the other side - this has been a LONG bull run and is clearly overbought already. The ascending triangle would seem to indicate it's got some more bullish energy left though. China is on the verge of approving it in the news...
Also in the news watch out if the White House issues an intellectual property waiver on vaccines . This most certainly could have a dramatic effect on the price action.
Bntx update. Longer view. We can expect a big move in next few wOnly good news coming out of BNTX. Today came 100% effectiveness in 12-15 year olds. When Marburg facility comes online they will be making bank on 50% share with Pfizer. Targeting 128 Pfizer entry, then a push 150+ before a pullback
Positions: 400 shares, 120/130c May, 150/160c June Lottos.
SRNE SORRENTO THERAPEUTICS BEST CEO EVER 10$ SHORT SQUEEZE Accurate Due Diligence in the links below. Best CEO ever, dr HENRY JI phd. Target price 10$ so he can unload his shares!
SRNE has 30% short interest. Short squeeze incoming
dont short it! dont ruin your family!
twitter.com
www.youtube.com
www.youtube.com
BIONTECH | BULLISH EXPECTATIONSWith the announcement of COVID-19 vaccine developments, Biontech shares saw a surge in price. In terms of technical analysis, it gave a bullish sign by breaking the resistance with high volume and a gap in the daily chart. Expecting a further increase in price in the upcoming dates and week.